Your browser doesn't support javascript.
loading
Serum tumor markers for the prediction of concordance between genomic profiles from liquid and tissue biopsy in patients with advanced lung adenocarcinoma.
Jiao, Xiao-Dong; Ding, Li-Ren; Zhang, Chuan-Tao; Qin, Bao-Dong; Liu, Ke; Jiang, Lian-Ping; Wang, Xi; Lv, Li-Ting; Ding, Hao; Li, Dao-Ming; Yang, Hui; Chen, Xue-Qin; Zhu, Wen-Yu; Wu, Ying; Ling, Yan; He, Xi; Liu, Jun; Shao, Lin; Wang, Hao-Zhe; Chen, Yan; Zheng, Jing-Jing; Inui, Naoki; Zang, Yuan-Sheng.
Afiliação
  • Jiao XD; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, China.
  • Ding LR; Department of Respiratory Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine at Bingjiang, Hangzhou, China.
  • Zhang CT; Department of Medical Oncology, The Affiliated Hospital of Qingdao University, Qingdao, China.
  • Qin BD; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, China.
  • Liu K; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, China.
  • Jiang LP; Department of Chemotherapy, Minhang Branch, Fudan University, Shanghai Cancer Center, Shanghai, China.
  • Wang X; Department of Oncology, The 903rd Hospital of PLA, Hangzhou, China.
  • Lv LT; Department of Oncology, Affiliated Hospital of Nantong University, Nantong, China.
  • Ding H; Division of Respiratory Disease, Affiliated People's Hospital of Jiangsu University, Zhenjiang, China.
  • Li DM; Department of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Yang H; Department of Medical Oncology, Suzhou Hospital Affiliated to Nanjing Medical University, Suzhou, China.
  • Chen XQ; Department of Oncology, Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Zhu WY; Department of Oncology, Changzhou No. 2 People's Hospital Cancer Center, Changzhou, China.
  • Wu Y; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, China.
  • Ling Y; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, China.
  • He X; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, China.
  • Liu J; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, China.
  • Shao L; Department of Data Science, Burning Rock Biotech, Guangzhou, China.
  • Wang HZ; Department of Data Science, Burning Rock Biotech, Guangzhou, China.
  • Chen Y; Department of Medicine, Burning Rock Biotech, Guangzhou, China.
  • Zheng JJ; Department of Medicine, Burning Rock Biotech, Guangzhou, China.
  • Inui N; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Handayama, Hamamatsu, Japan.
  • Zang YS; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, China.
Transl Lung Cancer Res ; 10(7): 3236-3250, 2021 Jul.
Article em En | MEDLINE | ID: mdl-34430361

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article